Publications by authors named "Nordqvist J"

Article Synopsis
  • The glycosylation of IgG is important for its interaction with immune cells, and estrogen levels can influence these processes, especially after menopause.
  • Researchers aimed to investigate how estrogen regulates IgG glycosylation in postmenopausal conditions using ovariectomized mice treated with estrogen.
  • The findings indicated that estrogen treatment enhanced certain glycosylation patterns on IgG without affecting overall glycoprotein sialylation, suggesting estrogen plays a role in modulating immune responses through its impact on IgG glycosylation.
View Article and Find Full Text PDF
Article Synopsis
  • Systemic lupus erythematosus (SLE) is an autoimmune disease more common in females, potentially linked to sex hormones, and the effects of a specific estrogen treatment (TSEC) on lupus-related organ damage remain unclear.
  • In a study involving ovariectomized mice, researchers tested how TSEC and other estrogen treatments affected B-cell development and kidney/salivary gland disease manifestations.
  • Results showed that TSEC did not worsen lupus symptoms in the mouse model and provided protection against bone loss, suggesting it could be a viable treatment option for osteoporosis and related symptoms in postmenopausal women with lupus.
View Article and Find Full Text PDF

Inflammation has a significant effect on bone remodeling and can result in bone loss via increased stimulation of osteoclasts. Activated immunoglobulins, especially autoantibodies, can increase osteoclastogenesis and are associated with pathological bone loss. Whether immunoglobulins and mature B lymphocytes are important for general bone architecture has not been completely determined.

View Article and Find Full Text PDF

Osteoporosis is a common secondary complication in patients with systemic lupus erythematosus (SLE). Current osteoporosis treatment with bisphosphonates has some negative side effects and there is a lack of data regarding newer treatments options for SLE associated osteoporosis. The tissue-selective estrogen complex (TSEC) containing conjugated estrogens and the selective estrogen receptor modulator bazedoxifene (Bza) is approved for treatment of postmenopausal vasomotor symptoms and prevention of osteoporosis.

View Article and Find Full Text PDF

Background: The DASH 7 is a recently published activity-related 7-item short form of the disability of the arm, shoulder, and hand (DASH) questionnaire developed to assess shoulder function in patients with subacromial pain. Before implementation in both intervention studies and in clinical practice, it is essential to evaluate its responsiveness. The objective of this study was to determine the minimal important change (MIC) in the DASH 7 questionnaire for patients with subacromial pain after a 3 months exercise intervention in a primary care context.

View Article and Find Full Text PDF

Objective: The primary aim was to describe the variability within clinical presentation of patients with subacromial pain in primary care, secondly to investigate associations between clinical presentation and self-reported pain intensity, shoulder function, level of anxiety and depression, and health-related quality of life.

Design And Setting: A cross-sectional study based on data from two clinical studies in primary care, one randomized controlled trial and one implementation study. Three components: active range of motion (AROM), rotator cuff function and scapular kinematics were analyzed to describe variability within clinical presentation and patient-reported measurements were used to investigate the impact on daily life.

View Article and Find Full Text PDF

Background/objective: Postmenopausal women with systemic lupus erythematosus have an increased risk of osteoporosis and associated fractures. Their increased osteoporosis risk is probably caused by a high level of inflammation, use of glucocorticoids, impaired kidney function, and early menopause as these are known risk factors for osteoporosis. Due to these risk factors and the lack of safe and effective treatments, new therapies for the treatment of osteoporosis in this group of patients are needed.

View Article and Find Full Text PDF

Background/objective: 17β-estradiol (E2) has major effects on the immune system. It induces thymic atrophy, inhibits both T and B lymphopoiesis and stimulates antibody production treatment with E2 has protective effects on the skeleton but is associated with negative side effects in reproductive organs. A tissue-selective estrogen complex (TSEC) comprise of estrogens combined with a selective estrogen receptor modulator (SERM).

View Article and Find Full Text PDF

Background: Subacromial pain is a common cause of shoulder dysfunction that negatively affects quality of life. Currently, most outcome measures for shoulder pain are applied to a heterogeneous group of patients. Of these measures, the Disabilities of the Arm, Shoulder, and Hand (DASH) is the most widely recognized test with which to assess patients with subacromial pain.

View Article and Find Full Text PDF